Jill Jortner is an investment analyst covering stocks in the health care services area in the U.S. Equity Division. She is an Investment Advisory Committee member of the Health Sciences Equity, US Dividend Growth Equity, and US Small-Cap Growth Equity Strategies. Jill is a vice president of T. Rowe Price Group, Inc.

Jill's investment experience began in 2004, and she has been with T. Rowe Price since 2022, beginning in the U.S. Equity Division. Prior to this, Jill was employed by Iridian Asset Management as a research analyst focused on health care services, life sciences, and medical technology.

Jill earned an M.B.A. from Northwestern University, Kellogg School of Management, and a B.A. in economics from Duke University.